Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4556-4559

  Chan, Michael H O Ming ^a   Mak, Tony Wing Lai ^a   Chiu, Rossa Wai Kwun ^a   Chow, Chun Chung ^b   Chan, Iris Hiu Shuen ^a   Lam, Christopher Wai Kei ^a,c  

^a NORTH DISTRICT HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOCALCIN; SIMVASTATIN;

ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HORMONE DETERMINATION; HUMAN; HYPERCHOLESTEROLEMIA; OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BONE AND BONES; COLLAGEN; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OSTEOCALCIN; PROSPECTIVE STUDIES; SIMVASTATIN;

ANIMALIA;

EID: 0034848003     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.9.4556     Document Type: Article

References (15)

1. Lovastatin prevents steroid induced adipogenesis and osteonecrosis
2. Protein synthesis is required for caspase activation and induction of apotosis by biphosphonates drugs
3. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein 2 in human osteosarcoma cells
4. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells
5. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
6. Oral statins and increased bone-mineral density in postmenopausal women
7. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
8. Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial
9. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: A simplified method and its clinical plausibility
10. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
11. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
12. Stimulation of bone formation in vitro and in rodents by statins
13. Molecular mechanism mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype
14. Anabolic therapy for osteoporosis
15. Hydrophilicity/lipophilicity: Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors